Literature DB >> 8504379

An overview of the older driver.

S M Retchin1, J Anapolle.   

Abstract

Although MVC rates are not substantially higher among older drivers after adjusting for mileage and may even be lower, the crash risk of the elderly driver remains a matter of increasing public concern. In part this is due to media attention over isolated cases of fatal MVCs involving older drivers, occasionally with a demented driver. This media attention has led to growing apprehension over the issue of elderly drivers. Physicians are likely to be involved increasingly in the evaluation of older drivers, whether they want to or not. The physician's quandary is the competing interests of the patient's well-being (i.e., continued independence), and the public's welfare (i.e., protection from impaired drivers). Unfortunately, there are no certain guidelines to protect the physician from liability for either of these conflicting duties. At issue is the foreseeability of harm from an elderly driver, either to self or to others. What degree of impairment is necessary before a physician is bound to report a patient to authorities? Although there are no clear answers, the best advice is to follow clinical judgment. One suggestion is to consider the diagnosis as suitable evidence. Thus, if the patient has a dementing illness of sufficient severity to warrant documentation in the medical record as a diagnosis, then perhaps the physician should consider advising the patient not to drive; reporting the patient to the appropriate authorities would be left to the physician's discretion after consultation with the patient's family. This might have the added benefit of obliging physicians to think twice before mislabeling patients with benign forgetfullness as demented, an all-too-frequent phenomenon. In this weighty ethical decision, it is critical for physicians to consider the consequences of removal of driving privileges from their elderly patients as well as their duty to protect the public health. Neither should be taken lightly. Above all else, physicians should not forsake their responsibility for advising either patients or the public regarding the driving privilege. To do so would simply relinquish the decision-making to those without clinical training or evaluative skills relevant to driving tasks. The physician's role in the evaluation of the elderly driver should be regarded as a pivotal challenge in the complicated management of the health of the elderly population.

Entities:  

Mesh:

Year:  1993        PMID: 8504379

Source DB:  PubMed          Journal:  Clin Geriatr Med        ISSN: 0749-0690            Impact factor:   3.076


  6 in total

1.  The role of physicians in assessing older drivers: barriers, opportunities, and strategies.

Authors:  Hillary R Bogner; Joseph B Straton; Joseph J Gallo; George W Rebok; Penelope M Keyl
Journal:  J Am Board Fam Pract       Date:  2004 Jan-Feb

Review 2.  Which older patients are competent to drive? Approaches to office-based assessment.

Authors:  David B Hogan
Journal:  Can Fam Physician       Date:  2005-03       Impact factor: 3.275

3.  Association between road vehicle collisions and recent medical contact in older drivers: a case-crossover study.

Authors:  Sandy Leproust; Emmanuel Lagarde; Samy Suissa; L Rachid Salmi
Journal:  Inj Prev       Date:  2007-12       Impact factor: 2.399

4.  Motor-vehicle crash history and licensing outcomes for older drivers reported as medically impaired in Missouri.

Authors:  Thomas M Meuser; David B Carr; Gudmundur F Ulfarsson
Journal:  Accid Anal Prev       Date:  2008-12-25

5.  A cross-sectional study of travel patterns of older adults in the USA during 2015: implications for mobility and traffic safety.

Authors:  Sijun Shen; Wilson Koech; Jing Feng; Thomas M Rice; Motao Zhu
Journal:  BMJ Open       Date:  2017-08-11       Impact factor: 2.692

6.  A randomized trial of a physical conditioning program to enhance the driving performance of older persons.

Authors:  Richard A Marottoli; Heather Allore; Katy L B Araujo; Lynne P Iannone; Denise Acampora; Margaret Gottschalk; Peter Charpentier; Stanislav Kasl; Peter Peduzzi
Journal:  J Gen Intern Med       Date:  2007-05       Impact factor: 5.128

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.